Education
About Us
Working with TipRanks
Follow Us
Beam Therapeutics (BEAM)
NASDAQ:BEAM
Beam Therapeutics (BEAM) Ownership Overview
1.60% Insiders
13.04% Mutual Funds
50.03% Other Institutional Investors
23.54% ETFs
11.80% Public Companies and Individual Investors
The ownership structure of Beam Therapeutics (BEAM) stock is a mix of institutional, retail, and individual investors. Approximately 86.61% of the company’s stock is owned by Institutional Investors, 1.60% is owned by Insiders, and 11.80% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $306627 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $6996576 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $175287119 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $204330250 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,928,111 | Institution | 9.87% | 171,259,915 | |
| 8,480,089 | Institution | 8.43% | 146,281,535 | |
| 8,334,646 | Institution | 8.29% | 143,772,644 | |
| 7,819,140 | Institution | 7.78% | 134,880,165 | |
| 6,398,452 | Institution | 6.36% | 110,373,297 | |
| 4,225,301 | Institution | 4.20% | 72,886,442 | |
| 1,628,233 | Institution | 1.62% | 28,087,019 | |
| 1,089,249 | Insider | 1.08% | 18,789,545 | |
| 877,809 | Institution | 0.87% | 15,142,205 | |
| 861,973 | Institution | 0.86% | 14,869,034 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,398,452 | Institution | 6.36% | 110,373,297 | |
| 861,973 | Institution | 0.86% | 14,869,034 | |
| 842,971 | Institution | 0.84% | 14,541,250 | |
| 745,225 | Institution | 0.74% | 12,855,131 | |
| 456,423 | Institution | 0.45% | 7,873,297 | |
| 410,000 | Institution | 0.41% | 7,072,500 | |
| 387,563 | Institution | 0.39% | 6,685,462 | |
| 312,550 | Institution | 0.31% | 5,391,488 | |
| 297,523 | Institution | 0.30% | 5,132,272 | |
| 296,329 | Institution | 0.29% | 5,111,675 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,746,628 | Institution | 5.71% | 102,807,175 | |
| 2,907,876 | Institution | 2.89% | 57,953,969 | |
| 2,345,476 | Institution | 2.33% | 41,960,566 | |
| 1,969,938 | Institution | 1.96% | 35,242,191 | |
| 1,897,833 | Institution | 1.89% | 47,066,258 | |
| 1,430,647 | Institution | 1.42% | 24,678,661 | |
| 1,386,298 | Institution | 1.38% | 27,628,919 | |
| 1,260,558 | Institution | 1.25% | 25,122,921 | |
| 832,123 | Institution | 0.83% | 14,886,680 | |
| 550,039 | Institution | 0.55% | 9,840,198 |
FAQ
Who Owns Beam Therapeutics (BEAM)?
According to the latest TipRanks data, approximately 50.03% of the company's stock is held by institutional investors, 1.60% is held by insiders, and 11.80% is held by retail investors.
What percentage of Beam Therapeutics (BEAM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.03% of Beam Therapeutics (BEAM) stock is held by institutional investors.
What percentage of Beam Therapeutics (BEAM) stock is held by retail investors?
According to the latest TipRanks data, approximately 11.80% of Beam Therapeutics (BEAM) stock is held by retail investors.
Who owns the most shares of Beam Therapeutics (BEAM)?
Andrew J.M. Spokes owns the most shares of Beam Therapeutics (BEAM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.